1. Lavalle S, Caruso S, Foti R, Gagliano C, Cocuzza S, La Via L, Parisi FM, Calvo-Henriquez C, Maniaci A. Behçet's Disease, Pathogenesis, Clinical Features, and Treatment Approaches: A Comprehensive Review. Medicina (Kaunas). 2024; 60(4):562. [
DOI:10.3390/medicina60040562]
2. Saint-André V, Charbit B, Biton A, Rouilly V, Possémé C, Bertrand A, Rotival M, Bergstedt J, Patin E, Albert ML, Quintana-Murci L, Duffy D; Milieu Intérieur Consortium. Smoking changes adaptive immunity with persistent effects. Nature. 2024; 626(8000):827-35. [
DOI:10.1038/s41586-023-06968-8]
3. Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020; 9(2):475. [
DOI:10.3390/cells9020475]
4. Chua MHY, Ng IAT, W L-Cheung M, Mak A. Association Between Cigarette Smoking and Systemic Lupus Erythematosus: An Updated Multivariate Bayesian Metaanalysis. J Rheumatol. 2020; 47(10):1514-21. [
DOI:10.3899/jrheum.190733]
5. Farouk, H.M., Abdel-Rahman, M.A. & Hassan, R.M. Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis. Egypt Rheumatol Rehabil. 2021; 48:26. [
DOI:10.1186/s43166-021-00076-z]
6. El Hasbani G, Madi M, Zoghbi MASE, Srour L, Uthman I, Jawad AS. The Impact of Tobacco Smoking on Systemic Sclerosis, Idiopathic Inflammatory Myositis, and Systemic Lupus Erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2024; 17:11795441241290522. [
DOI:10.1177/11795441241290522]
7. Roh S. Smoking as a Preventable Risk Factor for Rheumatoid Arthritis: Rationale for Smoking Cessation Treatment in Patients with Rheumatoid Arthritis. J Rheum Dis. 2019; 26(1):12-19. [
DOI:10.4078/jrd.2019.26.1.12]
8. Hu Y, Chen C, Yu F, Zhang J, Zeng H. The relationship between smoking and recurrent aphthous stomatitis: A Mendelian randomization study. Tob Induc Dis. 2025;23. [
DOI:10.18332/tid/199253]
9. Soy M, Erken E, Konca K, Ozbek S. Smoking and Behcet's disease. Clin Rheumatol. 2000;19(6):508-9. [
DOI:10.1007/s100670070020]
10. Rizvi SW, McGrath H. Jr, The therapeutic effect of cigarette smoking on oral/genital aphthosis and other manifestations of Behcet's disease. Clin Exp Rheumatol. 2001;19(5):S77-S8.
11. Kaklamani VG, Tzonou A, Markomichelakis N, Papazoglou S, Kaklamanis PG. The effect of smoking on the clinical features of Adamantiades-Behc¸et's disease. Adv Exp Med Biol. 2003; 528:323-27. [
DOI:10.1007/0-306-48382-3_64]
12. Bilgin AB, Turkoglu EB, Ilhan HD, Unal M, Apaydin KC. Is Smoking a Risk Factor in Ocular Behçet Disease? Ocul Immunol Inflamm. 2015; 23(4):283-86. [
DOI:10.3109/09273948.2014.909047]
13. Lee SS, Choi CB, Lee EK, Park SH, Choe JY, Kim SK. The association between smoking and clinical manifestations in patients with Behcet's disease. Korean J Med. 2008;75(2):202-9.
14. Tuna S, Alan S, Turkoglu EB. Effects of smoking and HLA-B51 on clinical manifestations in Behcet's disease: retrospective analysis of 209 patients in a Turkish population. Arch Rheumatol. 2015; 30(4):319-vii. [
DOI:10.5606/ArchRheumatol.2015.5600]
15. Torgutalp M, Eroğlu DŞ, Sezer S, Yayla ME, Karataş G, Özel EM, Dinçer A, Yüksel ML, Gülöksüz E, Yılmaz R, Turgay TM, Kınıklı G, Ateş A. Patient characteristics in Behçet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases. Scand J Rheumatol. 2022;51(1):50-8. [
DOI:10.1080/03009742.2021.1904622]
16. El-Shebiny E, El-Fakharany A, Zahran E, Shoeib S, Salem M, Elnaggar M, Morad N. Modifiable cardiovascular risk factors in patients with Behçet's disease: a multicenter experience. Egypt J Intern Med. 2019; 31(4):726-32. [
DOI:10.4103/ejim.ejim_112_19]
17. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The international criteria for Behçet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014; 28:338-47. [
DOI:10.1111/jdv.12107]
18. Lawton G, Bhakta B, Chamberlain M, Tennant A. The Behcet's disease activity index. Rheumatology 2004; 43(1):73-8. [
DOI:10.1093/rheumatology/keg453]
19. Malek Mahdavi A, Khabbazi A, Hajialilo M. Long-term outcome and predictors of remission in Behcet's disease in daily practice. Mod Rheumatol. 2021; 31(6):1148-57. [
DOI:10.1080/14397595.2021.1886623]
20. Piga M, Floris A, Espinosa G, Serpa Pinto L, Kougkas N, Lo Monaco A, et al. Development and preliminary validation of the Behcet's syndrome overall damage index (BODI). RMD Open. 2020; 6(2):e001192. [
DOI:10.1136/rmdopen-2020-001192]
21. Floreani A, Leung PS, Gershwin ME. Environmental Basis of Autoimmunity. Clin Rev Allergy Immunol. 2016; 50(3):287-300. [
DOI:10.1007/s12016-015-8493-8]
22. Costenbader K, Karlson E. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus. 2006; 15(11):737-45. [
DOI:10.1177/0961203306069344]
23. Lee YB, Lee JH, Lee SY, Lee JH, Yu DS, Han KD, Park YG. Association between smoking and Behçet's disease: a nationwide population-based study in Korea. J Eur Acad Dermatol Venereol. 2019; 33(11):2114-22. [
DOI:10.1111/jdv.15708]
24. Özer HT, Günesaçar R, Dinkçi S, Özbalkan Z, Yildiz F, Erken E. The impact of smoking on clinical features of Behcet's disease patients with glutathione S-transferase polymorphisms. Clin Exp Rheumatol. 2012; 30(3 Suppl 72):S14-17.
25. Gravina G, Wasén C, Garcia-Bonete MJ, Turkkila M, Erlandsson MC, Töyrä Silfverswärd S, Brisslert M, Pullerits R, Andersson KM, Katona G, Bokarewa MI. Survivin in autoimmune diseases. Autoimmun Rev. 2017; 16(8):845-55. [
DOI:10.1016/j.autrev.2017.05.016]
26. Addissouky TA, El Sayed IET, Ali MMA, Wang Y, El Baz A, Elarabany N, Khalil AA. Oxidative stress and inflammation: elucidating mechanisms of smoking-attributable pathology for therapeutic targeting. Bull Natl Res Cent. 2024; 48:16. [
DOI:10.1186/s42269-024-01174-6]
27. Guan Y, Li F, Li N, Yang P. Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances. J Neuroinflamm. 2024; 21(1):133. [
DOI:10.1186/s12974-024-03123-6]
28. Karimi S, Nouri H, Mahmoudinejad-Azar S, Abtahi SH. Smoking and environmental tobacco smoke exposure: implications in ocular disorders. Cutan Ocul Toxicol. 2023;42(1):1-7. [
DOI:10.1080/15569527.2022.2144874]
29. Nita M, Grzybowski A. Smoking and eye pathologies. A systemic review. Part II. Retina diseases, uveitis, optic neuropathies, thyroid-associated orbitopathy. Curr Pharm Des. 2017; 23(4):639-54. [
DOI:10.2174/1381612823666170111095723]
